Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6852)
All Articles published online
|
Publishing Process of This Article
|
Apr 26, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kanate AS, Pasquini MC, Hari PN, Hamadani M. Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions. World J Stem Cells 2014; 6(2): 69-81 [PMID: 24772235 DOI: 10.4252/wjsc.v6.i2.69] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v6/i2/69.htm |
| Number | Citing Articles |
| 1 |
Thomas C. Shea, Christine Walko, Yunro Chung, Anastasia Ivanova, Julia Sheets, Kamakshi Rao, Don Gabriel, Terry Comeau, William Wood, James Coghill, Paul Armistead, Stefanie Sarantopoulos, Jonathan Serody. Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients. Biology of Blood and Marrow Transplantation 2015; 21(12): 2129 doi: 10.1016/j.bbmt.2015.07.016
|
| 2 |
TaeHyung Kim, Joon Ho Moon, Jae-Sook Ahn, Yeo-Kyeoung Kim, Seung-Shin Lee, Seo-Yeon Ahn, Sung-Hoon Jung, Deok-Hwan Yang, Je-Jung Lee, Seung Hyun Choi, Ja-yeon Lee, Marc S. Tyndel, Myung-Geun Shin, Yoo Jin Lee, Sang Kyun Sohn, Seong-Kyu Park, Zhaolei Zhang, Hyeoung-Joon Kim, Dennis Dong Hwan Kim. Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse. Blood 2018; 132(15): 1604 doi: 10.1182/blood-2018-04-848028
|
| 3 |
Kayla V. Hamilton, Luke Maese, Jonathan M. Marron, Michael A. Pulsipher, Christopher C. Porter, Kim E. Nichols. Stopping Leukemia in Its Tracks: Should Preemptive Hematopoietic Stem-Cell Transplantation be Offered to Patients at Increased Genetic Risk for Acute Myeloid Leukemia?. Journal of Clinical Oncology 2019; 37(24): 2098 doi: 10.1200/JCO.19.00181
|
| 4 |
Davide Lazzarotto, Anna Candoni, Gianpaolo Nadali, Laura Pavan, Federica Lessi, Federico Mosna, Erica Simeone, Giovanna Ventura, Filippo Gherlinzoni, Gianpietro Semenzato, Giovanni Pizzolo, Renato Fanin. Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy. European Journal of Haematology 2016; 96(6): 586 doi: 10.1111/ejh.12635
|
| 5 |
Li-Ping Dou, Hong-Hua Li, Lu Wang, Fei Li, Wen-Rong Huang, Li Yu, Dai-Hong Liu. Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia. Chinese Medical Journal 2018; 131(7): 790 doi: 10.4103/0366-6999.228243
|
| 6 |
Mehmet Ozen, Mehmet Gunduz, Pervin Topcuoglu, Selami K. Toprak, Klara Dalva, Gunhan Gurman, Osman Ilhan. The effect of age on peripheral stem cell mobilization in healthy donors, single center experience. Journal of Clinical Apheresis 2017; 32(1): 16 doi: 10.1002/jca.21457
|
| 7 |
Daisuke Araki, Brent L. Wood, Megan Othus, Jerald P. Radich, Anna B. Halpern, Yi Zhou, Marco Mielcarek, Elihu H. Estey, Frederick R. Appelbaum, Roland B. Walter. Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease–Based Definition of Complete Remission?. Journal of Clinical Oncology 2016; 34(4): 329 doi: 10.1200/JCO.2015.63.3826
|
| 8 |
Nawid Albinger, Rita Pfeifer, Marcus Nitsche, Sarah Mertlitz, Julia Campe, Katja Stein, Hermann Kreyenberg, Ralf Schubert, Melissa Quadflieg, Dina Schneider, Michael W. M. Kühn, Olaf Penack, Congcong Zhang, Nina Möker, Evelyn Ullrich. Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia. Blood Cancer Journal 2022; 12(4) doi: 10.1038/s41408-022-00660-2
|
| 9 |
Barbara Nasilowska‐Adamska, Anna Czyz, Miroslaw Markiewicz, Piotr Rzepecki, Beata Piatkowska‐Jakubas, Monika Paluszewska, Monika Dzierzak‐Mietla, Iwona Solarska, Katarzyna Borg, Monika Prochorec‐Sobieszek, Richard Szydlo, Krzysztof Lewandowski, Aleksander Skotnicki, Wieslaw Wiktor Jedrzejczak, Slawomira Kyrcz‐Krzemien, Mieczyslaw Komarnicki, Krzysztof Warzocha. Mild chronic graft‐versus‐host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete remission: a retrospective study. European Journal of Haematology 2016; 96(3): 236 doi: 10.1111/ejh.12575
|
| 10 |
Letícia Baggio, Álvaro Macedo Laureano, Lucia Mariano da Rocha Silla, Dean Anthony Lee. Natural killer cell adoptive immunotherapy: Coming of age. Clinical Immunology 2017; 177: 3 doi: 10.1016/j.clim.2016.02.003
|
| 11 |
Guldane Seval, Muhit Ozcan. Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients. Journal of Clinical Medicine 2015; 4(3): 441 doi: 10.3390/jcm4030441
|
| 12 |
R C Lynn, Y Feng, K Schutsky, M Poussin, A Kalota, D S Dimitrov, D J Powell Jr. High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity. Leukemia 2016; 30(6): 1355 doi: 10.1038/leu.2016.35
|
| 13 |
Udo Holtick, Alexander Shimabukuro‐Vornhagen, Geothy Chakupurakal, Sebastian Theurich, Silke Leitzke, Anke Burst, Michael Hallek, Michael von Bergwelt‐Baildon, Christof Scheid, Jens M. Chemnitz. FLAMSA reduced‐intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission. European Journal of Haematology 2016; 96(5): 475 doi: 10.1111/ejh.12615
|
| 14 |
Liren Qian, Delia Dima, Cristian Berce, Yu Liu, Ioana Rus, Lajos-Zsolt Raduly, Yi Liu, Bobe Petrushev, Ioana Berindan-Neagoe, Alexandru Irimie, Alina Tanase, Ancuta Jurj, Jianliang Shen, Ciprian Tomuleasa. Protein dysregulation in graft versus host disease. Oncotarget 2018; 9(1): 1483 doi: 10.18632/oncotarget.23276
|
| 15 |
Nadja Hilger, Claudia Mueller, Lilly Stahl, Anne M. Mueller, Bianca Zoennchen, Sarah Dluczek, Christoph Halbich, Claudia Wickenhauser, Dennis Gerloff, Alexander A. Wurm, Gerhard Behre, Anna Kretschmer, Stephan Fricke. Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02408
|
| 16 |
Bianhong Wang, Yangyang Liu, Guangyuan Hou, Lili Wang, Na Lv, Yuanyuan Xu, Yihan Xu, Xiuli Wang, Zhaoling Xuan, Yu Jing, Honghua Li, Xiangshu Jin, Ailing Deng, Li Wang, Xiaoning Gao, Liping Dou, Junbin Liang, Chongjian Chen, Yonghui Li, Li Yu. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing. Oncotarget 2016; 7(22): 32065 doi: 10.18632/oncotarget.7028
|
| 17 |
Sijing Wu, Shijia Yang, Li Zhu, Ying Wang, Yicheng Zhang, Jianfeng Zhou, Dengju Li. Prognosis of Patients With de novo Acute Myeloid Leukemia Resistant to Initial Induction Chemotherapy. The American Journal of the Medical Sciences 2016; 351(5): 473 doi: 10.1016/j.amjms.2016.02.034
|
| 18 |
Ciprian Tomuleasa, Shigeo Fuji, Andrei Cucuianu, Markus Kapp, Valentina Pileczki, Bobe Petrushev, Sonia Selicean, Alina Tanase, Delia Dima, Ioana Berindan-Neagoe, Alexandru Irimie, Hermann Einsele. MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation. Annals of Hematology 2015; 94(7): 1081 doi: 10.1007/s00277-015-2369-0
|
| 19 |
Monazza Chaudhry, Natasha Ali. Reduced-intensity conditioning hematopoietic stem cell transplantation: looking forward to an international consensus. Blood Research 2015; 50(2): 69 doi: 10.5045/br.2015.50.2.69
|